Related Content

Current Perspectives on Multiple Sclerosis

MS manifests as neurologic signs and symptoms related to declining neuromuscular, sensory, and cognitive function, with a waxing and waning pattern of symptoms and/or continuous disease progression.

Early Management of Acute Ischemic Stroke: Focus on IV tPA and Timely Reperfusion

Recently updated guidelines have expanded the time window eligibility for treatment.

Muscular Dystrophy: Options for Complication Management

There are nine clearly defined types of muscular dystrophy, each differing in age of onset, clinical symptomology, muscle groups impacted, and associated complications.

Prevalence of Selected Sensory Disorders

For all such disorders, there are disparities between men and women in terms of prevalence.

DEA Form 106 and Loss of Controlled Substances

A pharmacy must report the theft or significant loss of controlled substances to the DEA within one business day.

Vitamin D Deficiency Prevalent in Children With T1D 5/17/2016

Cost of Insulin Triples in Decade; Price Versus Benefit Questioned 4/13/2016

Diabetic Peripheral Neuropathy: How Can We Help Our Patients? 3/17/2016

Proper foot care can help prevent many complications associated with this condition.

Combination Outperforms Intensified Basal Insulin for Lowering HbA1c 3/9/2016

Review Provides Information About Once-Weekly GLP-1RAs 2/10/2016

Antipsychotic Treatment Linked to Increased Diabetes Risk in Young Patients 2/3/2016

Pharmacists Help Diabetes Patients Lower A1c to Less Than 7% 1/27/2016

Ketoacidosis Risk Added to Labels of SGLT2 Inhibitors for Type 2 Diabetes 1/15/2016

Type 2 Diabetes Drug Reduces Risk of Heart Failure 12/14/2015

Indiscriminate, Insidious 11/16/2015

American Diabetes Month is a good time to highlight the sobering statistics of this widespread disease.

Analysis: No Link Found Between Insulin Dosage, Cardiovascular Mortality 11/13/2015

Medication Therapy Management Challenges in Patients With Diabetes: A Systematic Review 10/16/2015

Providing medication therapy management (MTM) for patients with diabetes presents many challenges.

Daily GLP-1 Agonist Injection Aids Weight Loss in Patients Without Diabetes 8/18/2015

Smart Insulin Patch Could Replace Painful Injections 7/20/2015

Drug for Diabetes May Lower Heart Attack Risk in HIV Patients 6/23/2015

LipidPlus: A Device to Monitor Lipid Profile and Blood Glucose 6/23/2015

This system provides rapid results without the use of venipuncture.

Dexcom G4 Platinum (Pediatric) Continuous Glucose Monitoring System 5/15/2015

This device is the only continuous glucose monitor approved for patients aged 2 to 17 years.

Connection Between Sleep Loss and Diabetes Explained 3/18/2015

Ammonium Lactate–Containing Moisturizers: A Systematic Review 11/17/2014

Patients with diabetes often experience foot complications, such as ulcers, infections, and even amputations.1

Cognitive Impairment and Dementia in Type 2 Diabetes Mellitus 10/16/2014

Through screening for early detection of cognitive impairment and dementia, patients have a better chance of managing their diabetes at home with provider assistance.

Managing Gestational Diabetes: The Clinical Pharmacist’s Role in a Patient-Centered Medical Home Model 9/17/2014

In this innovative practice model, pharmacists collaborate with women's health providers to educate patients.

Diabetic Peripheral Neuropathy 7/17/2014

Diabetic peripheral neuropathy is present in up to 10% of type 2 diabetes mellitus patients upon initial diagnosis.

Diabetic Foot Complications 6/19/2014

According to the American Diabetes Association (ADA), 60% to 70% of diabetes patients develop peripheral nerve damage.

MiniMed 530G: The First Artificial Pancreas 4/18/2014

This sensor-augmented pump monitors moment-to-moment glucose changes.

Blood Glucose Meters 10/18/2013

Self-monitoring of blood glucose is an important part of modern therapy for diabetes mellitus.

SGLT2 Inhibitors: A Review of Canagliflozin 10/18/2013

This novel medication for treatment of type 2 diabetes provides an alternative for patients who are not well controlled on current drug therapy or diet and exercise.

G4 Platinum Continuous Glucose Monitor 9/18/2013

The device measures blood glucose readings every 5 minutes for 7 days.

Diabetes Drug Shows Promise for Weight Loss 6/21/2013

View Full Article

Diabetic Peripheral Neuropathy 3/20/2013

Although it is not entirely clear why diabetes causes nerve damage, it is thought to be a result of poorly controlled blood glucose over a long period of time.

Antipsychotic-Induced Diabetes Mellitus 11/20/2012

Metabolic consequences of antipsychotic use include weight gain, hyperglycemia, and dyslipidemia.

Disordered Eating in Type 1 Diabetes: Insulin Omission and Diabulimia 5/22/2012

Young adults with diabetes are at increased risk for developing psychiatric comorbidities, including eating disorders, because of the complex nature of chronic disease management as well as the effects of chronic disease on psychosocial functioning.

Bariatric Surgery Reduces Diabetes 4/23/2012

Complications of Cellulitis in Diabetic Foot Infections 8/19/2011

Community pharmacists can play an integral role in educating patients about foot care and in recognizing ulcers that can lead to skin infections such as cellulitis.

Intensive Statin Therapy Confers Increased Risk of Diabetes 7/20/2011

Access to Rosiglitazone Restricted 6/20/2011

Bariatric Surgery for the Treatment of Type 2 Diabetes Mellitus: What Are the Options? 5/18/2011

Beyond weight management, these procedures may induce remission of T2DM. 

Study Shows Actos Prevents Onset of Type 2 Diabetes 4/20/2011

Understanding Diabetic Retinopathy 4/20/2011

Regular ophthalmic screenings help reduce the risk of this progressive eye disease. 

Diabetes and the Psychiatric Patient 11/17/2010

Management of metabolic complications, including diabetes mellitus and metabolic syndrome, in the psychiatric patient is complex.

Aspirin for Primary Prevention in Diabetes 10/20/2010

Based on evolving clinical evidence, the American Diabetes Association modified primary-prevention aspirin recommendations in 2010 to encompass only patients with a 10-year cardiovascular risk greater than 10%.

Smoking Linked to Elevated Diabetes Risk 10/20/2010

Survey Reveals Poor Insulin Adherence 10/20/2010

Avandia to Remain on the Market 8/19/2010

Diabetic Foot Ulcer Assessment and Treatment: A Pharmacist’s Guide 6/17/2010

Counseling, infection control, and treatment, all of which pharmacists are trained to perform, are of paramount importance.

The Times They Are a-Changin' 5/20/2010

A major health insurance company and pharmacy chain have partnered to offer patients with type 2 diabetes access to a new diabetes control program.

NCPA Partners With AADE to Expand Diabetes Counseling Options 10/21/2009

View Full Article

Gestational Diabetes Mellitus 9/21/2009

Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance that occurs with pregnancy or is first discovered during pregnancy. GDM, which is the most common metabolic complication associated with pregnancy, imposes risks on both mother and fetus.

View Full Article

Pharmacotherapy of Diabetes in the Elderly 7/20/2009

By optimizing medication use and reducing the risks of polypharmacy, the pharmacists plays a key role in decreasing morbidity and mortality in this patient population.

View Full Article

Optimal Management of Hyperglycemia in Hospitalized Patients 5/19/2009

In the United States, the number of people diagnosed with diabetes is staggering.

View Full Article

Managing Chronic Diabetic Peripheral Neuropathy in the Elderly 1/26/2009

Peripheral neuropathy (PN) is one of the most common complications of diabetes.

View Full Article

Intensive Insulin Therapy for Type 2 Diabetes 11/18/2008

T ype 2 diabetes mellitus (DM2) results from the combination of an insulin-secretory defect and peripheral insulin resistance.

View Full Article

Pharmacologic Management in Pediatric Type 1 Diabetes Mellitus 8/19/2008

T he American Diabetes Association (ADA) defines diabetes mellitus as a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both.

Caffeine Raises Blood Sugar in Patients with Type 2 Diabetes 7/18/2008

Researchers at Duke University have discovered that caffeine taken in even moderate doses could impair glucose control in patients with type 2 diabetes.

DPP-4 Inhibitors and the Quest for HbA1c Control 10/18/2007

Currently, there are 20.8 million people, or 7% of the U.

Inhaled, Dry Powder Insulin 10/18/2007

Diabetes mellitus (DM) currently affects an estimated 20.8 million people within the United States, with a current worldwide prevalence estimated at 180 million and which is expected to double by 2030.

How to Initiate, Titrate, and Intensify Insulin Treatment in Type 2 Diabetes 10/18/2007

Diabetes is a major public health problem that affects 7% of the United States population, or 20.8 million people.

Clinical News Digest 10/18/2007

Omega-3 Fatty Acids Reduce Risk of Type 1 Diabetes in Children Preliminary research published in a recent issue of JAMA suggests that the dietary intake of omega-3 fatty acids by children at increased genetic risk for type 1 diabetes is associated with a reduced risk of pancreatic islet autoimmunity, which is linked to the development of this disease.

At-Home Device for Glucose and Cholesterol Screening 9/19/2007

Diabetes is the fifth leading cause of death worldwide.